Your browser doesn't support javascript.
loading
Phosphatidylcholine-specific phospholipase C inhibition reduces HER2-overexpression, cell proliferation and in vivo tumor growth in a highly tumorigenic ovarian cancer model.
Paris, Luisa; Podo, Franca; Spadaro, Francesca; Abalsamo, Laura; Pisanu, Maria Elena; Ricci, Alessandro; Cecchetti, Serena; Altabella, Luisa; Buoncervello, Maria; Lozneanu, Ludmila; Bagnoli, Marina; Ramoni, Carlo; Canevari, Silvana; Mezzanzanica, Delia; Iorio, Egidio; Canese, Rossella.
Afiliação
  • Paris L; Department of Cell Biology and Neurosciences, Istituto Superiore di Sanità, 00161, Roma, Italy.
  • Podo F; Department of Cell Biology and Neurosciences, Istituto Superiore di Sanità, 00161, Roma, Italy.
  • Spadaro F; Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, 00161, Roma, Italy.
  • Abalsamo L; Department of Cell Biology and Neurosciences, Istituto Superiore di Sanità, 00161, Roma, Italy.
  • Pisanu ME; Department of Cell Biology and Neurosciences, Istituto Superiore di Sanità, 00161, Roma, Italy.
  • Ricci A; Department of Cell Biology and Neurosciences, Istituto Superiore di Sanità, 00161, Roma, Italy.
  • Cecchetti S; Department of Cell Biology and Neurosciences, Istituto Superiore di Sanità, 00161, Roma, Italy.
  • Altabella L; Department of Cell Biology and Neurosciences, Istituto Superiore di Sanità, 00161, Roma, Italy.
  • Buoncervello M; Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, 00161, Roma, Italy.
  • Lozneanu L; Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133, Milano, Italy.
  • Bagnoli M; Department of Histology, University of Medicine and Pharmacy "Grigore T. Popa", 700115, Iasi, Romania.
  • Ramoni C; Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133, Milano, Italy.
  • Canevari S; Department of Cell Biology and Neurosciences, Istituto Superiore di Sanità, 00161, Roma, Italy.
  • Mezzanzanica D; Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133, Milano, Italy.
  • Iorio E; Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133, Milano, Italy.
  • Canese R; Department of Cell Biology and Neurosciences, Istituto Superiore di Sanità, 00161, Roma, Italy.
Oncotarget ; 8(33): 55022-55038, 2017 Aug 15.
Article em En | MEDLINE | ID: mdl-28903399
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article